Clarity Pharmaceuticals Ltd - CU6 share price
About Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd is an Australian clinical-stage radiopharmaceutical company specializing in theranostic (therapy and imaging) products. They utilize their SAR Technology platform to develop innovative solutions for diagnosing, staging, and treating various types of cancers. Their three key products are SARTATE (targeting SSTR2-expressing cancers like neuroblastoma and neuroendocrine tumors), SAR-bisPSMA (targeting PSMA-expressing cancers, particularly prostate cancer), and SAR-Bombesin (used to identify and select patients for subsequent treatment of GRPr-expressing cancers like breast and prostate cancer). Clarity Pharmaceuticals is actively involved in multiple clinical trials, addressing both common and rare/orphan indications of cancer.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Try Veye Free for 7 Days
Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.
No credit card required
Price Chart (CU6)
TOP ASX STOCKS Worth Watching
- ✓ Instant Access
- ✓ No Credit Card Required
- ✓ Free to join · No spam
Free to join · No spam · Unsubscribe anytime
By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.
Discover the Top ASX Stocks to Invest in 2026!
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Latest Article
